Novo to partner with Anthropic on drug discovery efforts

Danish pharmaceutical company Novo Nordisk has announced a partnership with Anthropic, an AI research laboratory, to accelerate drug discovery efforts. This move comes as the company seeks to regain market share, following a 20% decline in its shares over the past year. While competitors like Lilly, Merck, and Roche have also invested in AI for productivity and clinical trials, Novo Nordisk aims to leverage AI for bioscience discovery.

The collaboration is part of a broader effort to revitalize the company, which has recently rebranded to simply "Novo."

Brief written by urgent.news from Semafor's own syndicated text. Machine-written — may contain errors; check the original before relying on it.